Alzheimer Disease Research Articles & Analysis
9 news found
Medical Director Jay Pathmanathan, MD, PhD, discussed how the company has applied its machine learning platform to standard electroencephalography (EEG) data to detect electrical disturbances in the brain that may predict cognitive decline and explain variability in disease course for patients with Alzheimer's disease. Pathmanathan's ...
Alfa Chemistry, a long-term partner for many pharmaceutical companies, universities, and research institutions, recently announced to offer donepezil, a synthetic active pharmaceutical ingredient (API) that can be used in pharmaceutical preparation for the treatment of Alzheimer's disease. ...
BioFINDER’s large comparison of blood plasma amyloid-beta assays found that the Washington University assay performed the best out of seven assays, including in the measurement of phosphorylated tau-217, an Alzheimer’s biomarker. Shorena Janelidze, a researcher at Sweden’s Lund University, presented the results at the ...
Further, prespecified exploratory analyses showed donanemab slowed the accumulation of tau across key brain regions in patients affected by Alzheimer's disease. "We are confident in the results of the TRAILBLAZER-ALZ study," said Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories. ...
Together, they will aim to enrich and measure circulating biomarkers for use in non-invasive early-stage Alzheimer’s Disease(AD) diagnostics and other applications in the global life sciences research and clinical in vitro diagnostics markets. It is estimated that 5.8 million Americans currently live with ...
Howard Fillit, Founding Executive Director and Chief Science Officer of the ADDF, said, "We need simple and cost-effective diagnostic tools and biomarkers that are critical to finding ways to prevent and treat Alzheimer's disease. With research efforts, such as DiamiR's epigenetics-based blood tests, we aim to accelerate the development of these ...
ByDiamiR
For years, neuroscientists have been working to determine which cellular processes allow humans to learn from experience and store memories, and how these processes are compromised by conditions such as schizophrenia and Alzheimer's disease. Now, researchers from the National Institute of Environmental Health Sciences (NIEHS), which is part of ...
For years, neuroscientists have been working to determine which cellular processes allow humans to learn from experience and store memories, and how these processes are compromised by conditions such as schizophrenia and Alzheimer's disease. Now, researchers from the National Institute of Environmental Health Sciences (NIEHS), which is part of ...
The 25th anniversary presentation of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease (AD) was held today honoring two noted researchers, Randy L. ...